Home
overview
The last quarter of 2007 saw 92 partnerships and deals in the drug delivery marketplace, of which licensing and co-development deals were the most prevalent. This surge in activity highlights the recognized need for the most effective delivery of life-saving drugs in a manner that is the least invasive and will enhance the quality of life for the recipients, as well as the importance of developments in drug delivery to transform the treatments for a wide variety of diseases.

SMi’s 5th Annual Drug Delivery Global Summit will bring together key decision makers in the pharmaceutical, biotech, and drug delivery fields. Covering the latest in nanotechnology, inhalational drug delivery and the latest breakthroughs in drug delivery technologies, don’t miss presentations by internationally recognised industry experts:
    Tomas Landh, Principal Scientist, Preformulation and Delivery, Novo Nordisk
    Tim Sparey, Associate Director, Merck
     
  • Matthew Roe, Senior Director, Genzyme
  • Stefan Bassarab, Director, Pharmaceutical Development, Boehringer-Ingelheim
  • Fredrik Tiberg, CEO, Camurus
  • Luk Chui Li, Director, Global Drug Delivery, Abbott
  • Nicola Bailey, Business Analyst, The Wellcome Trust
  • Fadi Eskandar, Principal Scientist, Novartis
  • Arif Shivji, Associate Director, Pfizer

If you are an Executive, Director or scientist working in the pharmaceutical or biotech industries within:

    • Drug Delivery
    • Drug Delivery Systems
    • Business Development
    • Licensing Strategy
    • Strategic Planning & Development
    • Technology Development
    • Marketing
    • Research & Development

then don't miss this opportunity to learn about the latest in:

    Pulmonary Drug Delivery: Arif Shivji, Sebastian Kaerger and Fadi Eskandar among the high calibre speakers presenting the latest on inhalational drug delivery

    siRNA Drug Delivery: Stefan Bassarab and Tim Sparey will be addressing th current uses, trends, challenges and solutions of siRNA drug delivery

    Novel Drug Delivery Systems: Fredrik Tiberg will be presenting novel drug delivery by lipid self-assembly

Conference programme

8:30 Registration & Coffee

9:00 Chairman's Opening Remarks

Tomas Landh

Tomas Landh, Director, Novo Nordisk

9:10 SOURCING AND PARTNERING ASPECTS OF DRUG DELIVERY

Tomas Landh

Tomas Landh, Director, Novo Nordisk

  • Understanding the incentives for large companies to seek small specialized external sources – “homework”
  • Capture strategic fits
  • Capture breakthrough/disruptive innovations
  • Capture needs – project based
  • Scouting and sourcing methodology
  • How to scout technologies - need based
  • How to scout potential breakthroughs?
  • The scouting and sourcing process in Discovery at Novo Nordisk
  • Enhancing the likelihood of a successful scouting process
  • The visibility in the pharmaceutical arena – both ways
  • Information of interest
  • Showcasing platforms
  • 9:50 THE CHALLENGES FACING SUCCESSFUL DELIVERY OF SIRNA

    Tim Sparey

    Tim Sparey, Associate Director, Scientific Liaison, Merck Sharp & Dohme

  • Modified siRNA and liposomes
  • Organ specific delivery
  • Collaborations to access new delivery modalities
  • 10:30 Morning Coffee

    11:00 PULMONARY APPLICATION OF OLIGONUCLEOTIDES

    Fadi Eskandar

    Fadi Eskandar, Principal Scientist, Novartis Pharmaceuticals

  • Key aspects of inhalation therapy
  • Challenges and opportunities surrounding inhalation of oligonucleotides
  • siRNA Targeting
  • Aerosol delivery technologies for siRNA
  • 11:40 DELIVERY OF PROTEIN AND PEPTIDE DRUGS WITH POLYSIALIC ACID: A NEW TECHNOLOGY PLATFORM IN THE CLINIC

    Peter Laing

    Peter Laing, Chief Operating Officer, Lipoxen Technologies Limited

  • Success and limitations of current drug delivery strategies for proteins and peptides
  • The need for better delivery technologies combining longevity of action and avoiding toxic and immunological side effects
  • Natural mechanisms that control longevity of proteins in the circulation
  • Natural mechanisms that avoid immunogenicity and antigenicity
  • Use of polysialic acid, a natural glycon, to achieve longevity and immune stealth
  • Clinical proof of principle for polysialic acid delivery - results of long acting EPO phase-I trial
  • 12:20 Networking Lunch

    13:50 DEVELOPING MEDICINES FOR THE ELDERLY

    Pilar Redondo

    Pilar Redondo, Head of Pharmaceutical Technology, NOSCIRA

    14:30 DRY AND PARTICULATE DOSAGEFORMS FOR THERAPEUTIC PROTEINS

    Stefan Bassarab

    Stefan Bassarab, Director of Pharma Development, Boehringer Ingelheim Pharma Germany

  • Alternative Dosageforms for Proteins
  • Powders, Chrystals, Nanoparticles
  • Examples of Current Developments
  • Impact on Biological Half Life
  • Impact on Shelf Life
  • New Dosageforms on the Market
  • 15:10 Afternoon Tea

    15:40 DRUG DELIVERY PARTNERING FOR SUCCESS

    Arif Shivji

    Arif Shivji, Associate Director, Pfizer

  • Understanding the role and requirements of in effective drug delivery partnerships
  • Understanding the environment & drivers for partnerships
  • Role of partnerships/ alliances in drug delivery
  • Success factors for alliances
  • 16:20 SUPERCRITICAL FLUID TECHNOLOGY: RECENT DEVELOPMENTS IN THE FIELD OF DRUG DELIVERY

    Joel Richard

    Joel Richard, Senior Director, Head of Drug Product Development, Ipsen

  • Improving formulation methods
  • From formulation to clinical trials to commercialisation
  • Examples of nanostructured API’s
  • Outlining the capabilities of particle engineering
  • 17:00 Chairman’s Closing Remarks and Close of Day One

    8:30 Registration & Coffee

    9:00 Chairman's Opening Remarks

    Tim Sparey

    Tim Sparey, Associate Director, Scientific Liaison, Merck Sharp & Dohme

    9:10 ENGINEERING NANOSYSTEMS TO IMPROVE BIOAVAILABILITY AND SOLUTBILITY

    Andreas Schatzlein

    Andreas Schatzlein, Reader, School of Pharmacy, University of London

  • Nanoparticle-based formulations for drug delivery
  • Tying them into various routes of administration
  • Uses of nanoparticle technology
  • Success stories of successful drug delivery
  • 9:50 ENHANZE TECHNOLOGY: APPLICATIONS TO SUBCUTANEOUS DELIVERY OF BIOLOGICS

    Igor Bilinsky

    Igor Bilinsky, Vice President of Business Development and Special Operations, Halozyme Therapeutics

  • Key challenges for subcutaneous delivery of biologics
  • Role of extracellular matrix in limiting subcutaneous drug dispersion
  • Effect of hyaluronidase on lowering dispersive and volume barriers of extracellular matrix
  • Opportunities for converting biologics from IV to SC route of administration
  • 10:30 Morning Coffee

    11:00 RE-ENGINEERING AN APPROVED POLYMER FOR NOVEL USES

    Donald Coppen

    Donald Coppen, Partnering & Licensing Manager, Biocompatibles UK Ltd

  • Phosphorylcholine - naturally biocompatible
  • Self-assembling diblock copolymer vesicle
  • Proposed endosomal escape mechanism
  • Oligonucleotide delivery & efficacy - promising early results
  • 11:40 THE DELIVERY AND ASSESSMENT OF CNS MEDICINES

    Matthew Roe

    Matthew Roe, Senior Director, Business Development & Licensing, Genzyme

  • Advancing drug carrier systems
  • Developing new cell culture models
  • Looking at cell therapy and gene therapy
  • Drug delivery to the brain across the blood-brain barrier
  • 12:20 Networking Lunch

    13:50 RECENT DEVELOPMENT IN FABRICATION TECHNOLOGIES OF POLYMERIC MICROSPHERES FOR PARENTERAL DRUG DELIVERY

    Luk Chiu Li

    Luk Chiu Li, Director, Global Drug Delivery, Abbott Laboratories

  • Review of existing fabrication methods
  • Super critical fluid technologies
  • Preparation of monosized microspheres
  • Micro-capacity spray drying method
  • 14:30 DRUG DELIVERY BY LIPID SELF ASSEMBLY: FLUIDCRYSTAL®

    Fredrik Tiberg

    Fredrik Tiberg, CEO, Camurus

  • Introduction to liquid crystal gels and colloids
  • Encapsulation and controlled release
  • Long-acting peptide and protein injectables
  • Bioadhesive topical drug delivery
  • 15:10 DELIVERING A FUNDING SOLUTION TO TRANSLATING TECHNOLOGY

    Nicola Bailey

    Nicola Bailey, Business Analyst, The Wellcome Trust
    View Bio

  • Background to the Wellcome Trust and Technology Transfer
  • Overview of Translational Funding
  • Examples of funded projects in the field of drug delivery
  • 15:50 Chairman’s Closing Remarks and Close of Conference

    16:00 Afternoon Tea

    +

    Workshops

    Nanotechnology and Drug-Device Integration
    Workshop

    Nanotechnology and Drug-Device Integration

    Copthorne Tara Hotel
    24th September 2008
    London, United Kingdom

    Copthorne Tara Hotel

    Scarsdale Place
    Kensington
    London W8 5SR
    United Kingdom

    Copthorne Tara Hotel

    The Copthorne Tara Hotel London Kensington is an elegant contemporary four-star hotel in prestigious Kensington, located just a two minutes walk from High Street Kensington underground station, making exploring easy. The hotel offers well-appointed and comfortable guest rooms combining Standard, Superior and Club accommodation. Club rooms offer iconic views over the city and include Club Lounge access for complimentary breakfast and refreshments. Guests can sample the authentic Singaporean, Malaysian and Chinese cuisine at Bugis Street, traditional pub fare at the Brasserie Restaurant & Bar or relax with a delicious drink at West8 Cocktail Lounge & Bar.

    The Copthorne Tara Hotel boasts 745 square meters of flexible meeting space, consisting of the Shannon Suite and the Liffey Suite, ideal for hosting conferences, weddings and social events. Facilities include access to the business centre 24 hours a day, fully equipped fitness room, gift shop, theatre desk and Bureau de Change. With ample onsite parking outside the London congestion charge zone and excellent transport links via Heathrow Airport, the hotel is the perfect location for business or leisure stays. The hotel is within close proximity to the shops of High Street Kensington, Knightsbridge and Westfield London, Olympia Conference Centre, Royal Albert Hall, Kensington Palace and Hyde Park.

     

    HOTEL BOOKING FORM

    Title

    SubTitle
    speaker image

    Content


    Title


    Description

    Download


    WHAT IS CPD?

    CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

    ‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

    CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

    Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

    CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.

    CPD AND PROFESSIONAL INSTITUTES

    There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

    For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

    CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.

    TYPICAL CPD SCHEMES AND RECORDING OF CPD (CPD points and hours)

    Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

    ‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

    ‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

    The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

    As a formal provider of CPD certified activities, SMI Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.

    GLOBAL CPD

    Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

    CPD Certificates

    We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@smi-online.co.uk

    Event Title

    Headline

    Text
    Read More

    I would like to speak at an event

    I would like to attend an event

    I would like to sponsor/exhibit at an event

    SIGN UP OR LOGIN

    Sign up
    Forgotten Password?

    Contact SMi GROUP LTD

    UK Office
    Opening Hours: 9.00 - 17.30 (local time)
    SMi Group Ltd, 1 Westminster Bridge Road, London, SE1 7XW, United Kingdom
    Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
    Website: http://www.smi-online.co.uk Email: events@smi-online.co.uk
    Registered in England No: 3779287 VAT No: GB 976 2951 71




    Forgotten Password

    Please enter the email address you registered with. We will email you a new password.